Covestor’s Repare Therapeutics RPTX Stock Holding History

Covestor’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,627	Closed	-$35K	–	2699
2025 Q4	$35K	Buy	+13,627	New	+$27.4K	0.02%	1043

Covestor's RPTX Position: Q1 2026 in Review

Covestor sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 13,627 shares — an estimated $35K sold.

Covestor first reported a position in RPTX in Q4 2025 and held it in 1 quarter. The position peaked at $35K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Covestor reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Covestor sold 13,627 Repare Therapeutics shares in Q1 2026, an estimated $35K.
Covestor first reported a position in Repare Therapeutics in Q4 2025 and held it in 1 quarter.
Covestor's Repare Therapeutics position peaked at $35K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.